Format

Send to

Choose Destination
Contraception. 2013 Nov;88(5):671-3. doi: 10.1016/j.contraception.2013.07.008. Epub 2013 Jul 29.

Administration of the etonogestrel contraceptive implant on the day of mifepristone for medical abortion: a pilot study.

Author information

1
Department of Obstetrics and Gynecology, Boston University Medical Center. Electronic address: Sarita.Sonalkar@bmc.org.

Erratum in

  • Contraception. 2014 Feb;89(2):142. Hou, Melody [corrected to Hou, Melody Y].

Abstract

OBJECTIVE:

We sought to determine satisfaction and continuation rates of the contraceptive implant when placed on the initial visit for first-trimester medical abortion.

STUDY DESIGN:

In this pilot study, we placed the implant within 15 min of mifepristone administration. We assessed satisfaction with implant placement timing, 1-year implant continuation and abortion completion.

RESULTS:

We enrolled 20 participants. Sixteen (80%) returned for follow-up, and all had complete abortion. At 1 year, of 16 participants contacted, 14 (87.5%) were satisfied with implant insertion timing, and 14 (87.5%) continued the implant.

CONCLUSIONS:

Initiation of the contraceptive implant on the initial visit for medical abortion resulted in high satisfaction and continuation rates.

IMPLICATIONS:

This pilot study provides important groundwork for future larger studies to assess initiation of the contraceptive implant on the day of mifepristone for medical abortion.

TRIAL REGISTRATION:

ClinicalTrials.gov NCT01356927.

KEYWORDS:

First-trimester abortion; Long-acting reversible contraception

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center